Cited by 353Mesenchymal stem cell researchNeurogenesis and neuroplasticity mechanismsStroke Rehabilitation and Recovery

Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke

Open access
Shen, Li Hong, Li, Yi, Chen, Jieli, Zacharek, Alex, Gao, Qi, Kapke, Allissa, Lu, Mei, Raginski, Kim +3 more·2007·Journal of Cerebral Blood Flow & Metabolism

Abstract

Bone marrow stromal cells (BMSCs) facilitate functional recovery in rats after stroke when administered acutely (1 day) or subacutely (7 days). In this study, we postponed the time of cell transplantation to 1 month after stroke. Female retired breeder rats were subjected to 2 h of middle cerebral artery occlusion (MCAo). Male BMSCs (3×10 6) or phosphate-buffered saline were administered intravenously, and the animals were killed 3 months later. An additional population of nontreated rats was killed at 1 month after MCAo. Significant recovery of behavior was found in BMSC-treated rats beginning at 1 month after cell injection in the modified neurologic severity score test and the adhesive-removal test compared with control animals ( P < 0.05). In situ hybridization showed that BMSCs survived and preferentially localized to the ipsilateral hemisphere. Double staining revealed that approximately 13% and 6% Y-chromosome-positive cells expressed the astrocyte marker, glial fibrillary acidic protein, and the neuronal marker, microtubule-associated protein-2, respectively. In addition, BMSC treatment reduced scar thickness, and increased the number of proliferating cells and oligodendrocyte precursor cells along the subventricular zone in the ipsilateral hemisphere. Expression of the chemokine stromal-cell-derived factor-1 (SDF-1) was significantly increased along the ischemic boundary zone compared with the corresponding areas in the contralateral hemisphere at 1 month and 4 months ( P < 0.01) after stroke. The SDF-1 receptor, CXC-chemokine receptor-4 (CXCR4), was expressed in BMSCs both in vitro and in vivo. Our data show that the time window of BMSC therapy is at least 1 month after stroke; the interaction of SDF-1/CXCR4 may contribute to the trafficking of transplanted BMSCs.

Integrity signals

Registry

Crossref · 10.1038/sj.jcbfm.9600311

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shen, L. H., Li, Y., Chen, J., Zacharek, A., Gao, Q., Kapke, A., Lu, M., Raginski, K., Vanguri, P., Smith, A., & Chopp, M.
Affiliations
Henry Ford Health (US)
Corresponding author
Chopp, Michael
Venue
Journal of Cerebral Blood Flow & Metabolism
Published
2007-01
Volume
27
Issue
1
Pages
6-13
ISSN
  • 0271-678X (ISSN-L)
  • 1559-7016
OpenAlex
W2080638375
Cited by
353
References
27
Citations by year
2026: 2 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 15 · 2019: 12 · 2018: 17 · 2017: 13 · 2016: 27 · 2015: 26 · 2014: 29 · 2013: 29 · 2012: 22
FWCI
11.98
Type
journal article
Language
en
Open access
Locations
  • Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Neurological Disorders and Stroke (P01NS23393, R01NS045041, P01NS023393, P01NS042345, R01 NS45041)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
Keywords
mesenchymal stem cells, stroke, middle cerebral artery occlusion, functional recovery, SDF-1/CXCR4, cell trafficking, oligodendrocyte precursor cells, subventricular zone, glial scar, astrocytes, MAP2
MeSH terms
Animals, Behavior, Animal, Female, Immunoglobulins, Immunohistochemistry, Male, Membrane Glycoproteins, Physical Stimulation, Psychomotor Performance, Biomarkers, Bone Marrow Transplantation, Stromal Cells, Rats, Wistar, In Situ Hybridization, Fluorescence, Receptors, CXCR4, Chemokines, CXC, Reverse Transcriptase Polymerase Chain Reaction, Infarction, Middle Cerebral Artery, Stroke, Rats, Chemokine CXCL12

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review